Merck KGaA Return on Equity (ROE) Growth & History (MRK)
Merck KGaA's return on equity was 8.94% for fiscal 2025.
View full Merck KGaA company overviewMerck KGaA annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 8.94% | −0.91 pp |
| 2024 | 2024-12-31 | 9.85% | −0.93 pp |
| 2023 | 2023-12-31 | 10.77% | −3.35 pp |
| 2022 | 2022-12-31 | 14.13% | −1.88 pp |
| 2021 | 2021-12-31 | 16.01% | +4.56 pp |
| 2020 | 2020-12-31 | 11.46% | +3.90 pp |
| 2019 | 2019-12-31 | 7.55% | −14.22 pp |
| 2018 | 2018-12-31 | 21.77% | +3.12 pp |
| 2017 | 2017-12-31 | 18.65% | +6.45 pp |
| 2016 | 2016-12-31 | 12.20% | +3.03 pp |
| 2015 | 2015-12-31 | 9.17% | −1.07 pp |
| 2014 | 2014-12-31 | 10.23% | −1.08 pp |
| 2013 | 2013-12-31 | 11.31% | +5.74 pp |
| 2012 | 2012-12-31 | 5.57% | −0.49 pp |
| 2011 | 2011-12-31 | 6.05% | — |
Merck KGaA quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | 2.26% | — |
| Q4 2025 | 2025-12-31 | 1.11% | — |
| Q3 2025 | 2025-09-30 | 3.15% | — |
| Q2 2025 | 2025-06-30 | 2.25% | — |
Merck KGaA return on equity trends
Over the last five fiscal years, Merck KGaA's return on equity decreased from 11.46% to 8.94%, a change of −2.52 percentage points. The latest reported quarter, Q1 2026, shows 2.26%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Merck KGaA source filings ↗